Rules of Practice and Procedure for Hearings

The PMPRB´s regulatory mandate is to ensure that prices at which patentees sell their patented medicines in Canada are not excessive.

In the event that the price of a patented medicine appears to be excessive, the Board can hold a public hearing and, if it finds that the price is excessive, it may issue an order to reduce the price and to offset revenues received as a result of excessive prices. Board decisions are subject to judicial review in the Federal Court of Canada.

The Rules of Practice and Procedure is a published standard set of procedures for all participants to follow in hearings before the Board. The Rules set out the Board´s procedures in accordance with the requirement under the Patent Act to resolve matters as informally and expeditiously as the circumstances and considerations of fairness permit.

To download a copy of the Rules, click on:

When scheduling a hearing, the Board makes a reasonable effort to accommodate the parties to the proceedings. Parties that may appear before the Board should be familiar with the Direction on Scheduling Hearing Dates.

Date modified: